IRadimed Corp
NASDAQ:IRMD

Watchlist Manager
IRadimed Corp Logo
IRadimed Corp
NASDAQ:IRMD
Watchlist
Price: 51.66 USD -1.69%
Market Cap: 657.1m USD

Intrinsic Value

The intrinsic value of one IRMD stock under the Base Case scenario is 33.12 USD. Compared to the current market price of 51.66 USD, IRadimed Corp is Overvalued by 36%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

IRMD Intrinsic Value
33.12 USD
Overvaluation 36%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
IRadimed Corp

Valuation History Unavailable

Historical valuation for IRMD cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about IRadimed Corp
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
IRadimed Corp

Current Assets 75.1m
Cash & Short-Term Investments 50.3m
Receivables 12.7m
Other Current Assets 12.1m
Non-Current Assets 26.6m
PP&E 20.4m
Intangibles 3.3m
Other Non-Current Assets 2.9m
Efficiency

Free Cash Flow Analysis
IRadimed Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
IRadimed Corp

Revenue
75.2m USD
Cost of Revenue
-17.3m USD
Gross Profit
57.8m USD
Operating Expenses
-35.2m USD
Operating Income
22.6m USD
Other Expenses
-2.9m USD
Net Income
19.8m USD
Fundamental Scores

IRMD Profitability Score
Profitability Due Diligence

IRadimed Corp's profitability score is 73/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Gross Profit
Positive Free Cash Flow
Exceptional ROIC
73/100
Profitability
Score

IRadimed Corp's profitability score is 73/100. The higher the profitability score, the more profitable the company is.

IRMD Solvency Score
Solvency Due Diligence

IRadimed Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

IRadimed Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IRMD Price Targets Summary
IRadimed Corp

Wall Street analysts forecast IRMD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IRMD is 72.42 USD with a low forecast of 70.7 USD and a high forecast of 75.6 USD.

Lowest
Price Target
70.7 USD
37% Upside
Average
Price Target
72.42 USD
40% Upside
Highest
Price Target
75.6 USD
46% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for IRMD is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

IRMD Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one IRMD stock?

The intrinsic value of one IRMD stock under the Base Case scenario is 33.12 USD.

Is IRMD stock undervalued or overvalued?

Compared to the current market price of 51.66 USD, IRadimed Corp is Overvalued by 36%.

Back to Top